APA   Click to copy
Hude, I., Sasse, S., Bröckelmann, P. J., von Tresckow, B., Momotow, J., Engert, A., & Borchmann, S. (2018). Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition. British Journal of Haematology, 181(6), 837–840.

Chicago/Turabian   Click to copy
Hude, Ida, Stephanie Sasse, Paul J. Bröckelmann, Bastian von Tresckow, Jesko Momotow, Andreas Engert, and Sven Borchmann. “Leucocyte and Eosinophil Counts Predict Progression-Free Survival in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated with PD1 Inhibition.” British Journal of Haematology 181, no. 6 (May 1, 2018): 837–840.

MLA   Click to copy
Hude, Ida, et al. “Leucocyte and Eosinophil Counts Predict Progression-Free Survival in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated with PD1 Inhibition.” British Journal of Haematology, vol. 181, no. 6, May 2018, pp. 837–40.

@article{ida2018a,
  title = {Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.},
  year = {2018},
  month = may,
  day = {1},
  issue = {6},
  journal = {British Journal of Haematology},
  pages = {837-840},
  volume = {181},
  author = {Hude, Ida and Sasse, Stephanie and Bröckelmann, Paul J. and von Tresckow, Bastian and Momotow, Jesko and Engert, Andreas and Borchmann, Sven},
  month_numeric = {5}
}